Navigation Links
Team ZERO to Run to End Prostate Cancer in 2009 Marathons
Date:4/9/2009

Runners Encouraged to Join ZERO -- The Project to End Prostate Cancer to Take Strides for the Cause

WASHINGTON, April 9 /PRNewswire-USNewswire/ -- Spring is in the air across the country and runners are hitting the pavement to ramp up their running regimes in preparation for upcoming races. ZERO -- The Project to End Prostate Cancer has joined forces with the Bank of America Chicago Marathon and the Marine Corps Marathon to build upon its Team ZERO endurance program and has formed teams to run in both races. If you want to run for a great cause -- ending prostate cancer -- Team ZERO is the team to join in 2009.

ZERO recognizes that maintaining a healthy and active lifestyle helps prevent many diseases, including prostate cancer. Team ZERO is a training program for individuals who wish to participate in races across the country to raise funds for prostate cancer education, screenings and research. This training program matches runners up with the races they'd like to run while helping end prostate cancer. Participating on this team can, in some cases, guarantee you a spot for a competitive run such as a large marathon.

ZERO formed its first team for the 2008 Marine Corps Marathon in Washington, DC on Oct. 26, 2008.

"Running has always been a passion of mine," said Jamie Bearse, COO of ZERO -- The Project to End Prostate Cancer and captain for Team ZERO for the 2008 Marine Corps Marathon. "I'm also passionate about ending prostate cancer which affects one in six American men. The opportunity to run on Team ZERO for my first marathon was the perfect way to combine my passions for a great cause!"

Slots are still available on Team ZERO for both the Bank of America Chicago Marathon on Oct. 11 and the Marine Corps Marathon on Oct. 25. To learn more about Team ZERO and to sign up, visit www.ZeroCancer.org/GI_Active_Events.

About ZERO -- The Project to End Prostate Cancer (ZeroCancer.org)

Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. Our name conveys what we stand for -- zero tolerance for prostate cancer.

At ZERO, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.


'/>"/>
SOURCE ZERO -- The Project to End Prostate Cancer
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Drug shows activity in men with advanced prostate cancer
2. Stress Management Battles Prostate Cancer Anxiety
3. New Prostate Cancer Drug May Hold Promise
4. Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer
5. A potential new target for treatment of hormone refractory prostate cancer
6. Interviewed Experts Expect Taxotere to Increase Overall Survival More Than Other Drugs, Including Lupron Depot, in Stage III Prostate Cancer
7. Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery
8. Fox Chase is first cancer center in the nation to use MRI-guided biopsy to detect prostate cancer
9. Free Community Seminar; Reviews Treatment Options for Enlarged Prostate
10. Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months
11. Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... 08, 2016 , ... GrassrootsHealth published data from its D*action ... diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than a ... health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of ...
(Date:2/8/2016)... ... 08, 2016 , ... The schedule is now online for the ... Conference, which is being held May 25-29 at the Loews Chicago O’Hare Hotel, continues ... and causes of chronic illness in children. , Very recent articles have cited 1 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , February 8, 2016 ... report published by Allied Market Research titled, "World ... and Forecasts, 2014-2020", estimates the world synthetic biology ... synthesis and sequencing technology segment would continue to ... software tools segment, collectively, held around half of ...
(Date:2/5/2016)... N.C. , Feb. 5, 2016  Despite the ... been slower than other industries to embrace Big Data ... with utilization. On the medical side, organizations have begun ... everything from clinical trials to adherence. ... from benchmarking firm Best Practices, LLC, Big Data has ...
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
Breaking Medicine Technology: